市场调查报告书
商品编码
1411616
避孕药市场:依产品、年龄层、给药途径、分布 - 全球预测 2024-2030Contraceptive Pills Market by Product (Combination Pill, Continuous/Extended Pill, Progesterone Pill), Age Group (15-24, 25-34, 35-44), Route of Administration, Distribution - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年避孕药具市场规模为195.3亿美元,预计2024年将达207.6亿美元,2030年将达302.7亿美元,复合年增长率为6.46%。
全球避孕药市场
主要市场统计 | |
---|---|
基准年[2023] | 195.3亿美元 |
预测年份 [2024] | 207.6亿美元 |
预测年份 [2030] | 302.7亿美元 |
复合年增长率(%) | 6.46% |
避孕药是含有合成荷尔蒙的口服药物,旨在调节女性的月经週期并防止意外怀孕。这些药物的主要作用是抑制排卵、改变子宫颈黏液以限制精子的通过,以及改变子宫内膜以最大限度地减少受精卵的着床。不同年龄层和文化对计划生育方法的认识不断提高,对安全有效避孕药具的需求也随之增加。然而,由于市场上有替代避孕方法和不合格产品,消费者取得避孕药具的机会受到限制。然而,开拓具有更高功效和更少副作用的新配方预计将为避孕市场提供潜在机会。
区域洞察
在美洲,由于广泛的宣传宣传活动、政府支持以及製造商在新避孕药配方方面的技术进步,避孕药市场正在扩大。根据美国国家医学图书馆 (NLM) 的数据,目前美国15 岁至 44 岁的女性中约有 25% 选择避孕药作为避孕方法。在欧洲地区,促进计划生育教育和负担能力的公共卫生计划使避孕药具的使用变得流行。亚太地区面临中国和印度等人口稠密的经济体,创造了对负担得起的避孕药具的需求并呈现出市场成长前景。此外,许多新兴和开发中国家正在透过推出计划生育教育和宣传计划为市场创造机会。
FPNV定位矩阵
FPNV定位矩阵对于评估避孕市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出资讯的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对避孕市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵考察,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更资讯的决策并制定有效的策略,从而在市场上获得竞争优势。
1-市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2-市场开拓:我们深入研究利润丰厚的新兴市场,并分析它们在成熟细分市场中的渗透率。
3- 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4-竞争力评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5- 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1-避孕药市场的市场规模和预测是多少?
2-避孕药市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些?
3-避孕市场的技术趋势和法律规范是什么?
4-避孕药市场主要供应商的市场占有率是多少?
5-进入避孕药具市场的适当型态或策略手段是什么?
[182 Pages Report] The Contraceptive Pills Market size was estimated at USD 19.53 billion in 2023 and expected to reach USD 20.76 billion in 2024, at a CAGR 6.46% to reach USD 30.27 billion by 2030.
Global Contraceptive Pills Market
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 19.53 billion |
Estimated Year [2024] | USD 20.76 billion |
Forecast Year [2030] | USD 30.27 billion |
CAGR (%) | 6.46% |
Contraceptive pills are oral medications that contain synthetic hormones designed to regulate a woman's menstrual cycle and prevent unintended pregnancy. These pharmaceutical products primarily function by inhibiting ovulation, altering the cervical mucus to restrict sperm passage, and modifying the endometrial lining to minimize implantation of a fertilized egg. The growing awareness about family planning methods among different age groups and cultures has increase the demand for safe and effective contraceptives. However, the presence of alternative contraceptive methods or substandard products in the market limits consumers' utilization of contraceptive pills. Nevertheless, developing new formulations that offer improved efficacy and fewer side effects is expected to create potential opportunities for the contraceptive pills market.
Regional Insights
In the Americas region, the contraceptive pills market is growing owing to widespread awareness campaigns, government support, and technological advancements from manufacturers for new contraceptive pill composition. According to the National Library of Medicine (NLM), Approximately 25% of women in the U.S. aged 15-44 currently use contraception pills as their method of choice. In the European region, public health programs promoting family planning education and affordable prices have gained popularity for the use of contraceptive pills. The Asia Pacific region showcases growth prospects for the market in the face of larger population economies such as China & India, creating demand for affordable contraceptive pills. Further, many emerging & developing countries create an opportunistic landscape for the market through the adoption of family planning education & awareness programs.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Contraceptive Pills Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Contraceptive Pills Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Contraceptive Pills Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Afaxys Pharma, LLC, Amneal Pharmaceuticals, Inc., Apotex Inc., Aurobindo Pharma Limited, Bayer AG, Bionpharma Inc., Cipla Limited, Combe Incorporated, Gedeon Richter PLC, Glenmark Pharmaceuticals Limited, Johnson & Johnson Services, Inc., Julie Product Inc., Lupin Limited, Mankind Pharma Ltd., Mayne Pharma Group Limited, Merck & Co., Inc., Northstar Rx LLC, Perrigo Company plc, Pfizer Inc., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Limited, Syzygy Healthcare Solutions, LLC, Teva Pharmaceuticals, Viatris Inc., and Xiromed, LLC.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Contraceptive Pills Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Contraceptive Pills Market?
3. What are the technology trends and regulatory frameworks in the Contraceptive Pills Market?
4. What is the market share of the leading vendors in the Contraceptive Pills Market?
5. Which modes and strategic moves are suitable for entering the Contraceptive Pills Market?